SEC Stock Data Quick Answer XTL BIOPHARMACEUTICALS LTD reported R&D Expense of $98.0 thousand for fiscal year 2024. XTL BIOPHARMACEUTICALS LTD R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $98.0K +216.1% 2023 $31.0K +3.3% 2022 $30.0K +0.0% 2021 $30.0K -21.1% 2020 $38.0K +8.6% 2019 $35.0K -7.9% 2018 $38.0K -11.6% 2017 $43.0K -90.3% 2016 $443.0K … Read more
Quick Answer XTL BIOPHARMACEUTICALS LTD reported Total Assets of $8.55 million for fiscal year 2024. XTL BIOPHARMACEUTICALS LTD Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $8.55M +46.4% 2024 $5.84M +140.8% 2023 $2.43M -42.0% 2022 $4.19M -36.7% 2021 $6.62M +1.8% 2020 $6.50M -9.8% 2019 $7.21M -15.9% 2018 $8.57M +30.2% 2017 $6.59M … Read more
Quick Answer XTL BIOPHARMACEUTICALS LTD reported Total Assets of $8.55 million for fiscal year 2024. XTL BIOPHARMACEUTICALS LTD — Key Financials by Year Metric 2024 2023 2022 2021 2020 2019 Total Assets $5.84M+140.8% $2.43M-42.0% $4.19M-36.7% $6.62M+1.8% $6.50M-9.8% $7.21M-15.9% R&D Expense $98.0K+216.1% $31.0K+3.3% $30.0K+0.0% $30.0K-21.1% $38.0K+8.6% $35.0K-7.9% Gross Profit $3.0K — — — — — XTL … Read more
Quick Answer XTI Aerospace, Inc. reported Shares Outstanding of 1.69 million shares for fiscal year 2024. XTI Aerospace, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 1.69M +13073.5% 2023 12,791 -64.2% 2022 35,709 -97.9% 2021 1.73M -96.7% 2020 53.18M +1155.7% 2019 4.23M +11945.4% 2018 35,158 +46.2% 2017 24,042 -66.5% 2016 … Read more
Quick Answer XTI Aerospace, Inc. reported Gross Profit of $1.89 million for fiscal year 2024. XTI Aerospace, Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2024 $1.89M -39.2% 2023 $3.10M -22.2% 2022 $3.99M -65.7% 2021 $11.62M +73.9% 2020 $6.68M +42.5% 2019 $4.69M +75.1% 2018 $2.68M -0.9% 2017 $2.70M -81.9% 2016 $14.93M … Read more
Quick Answer XTI Aerospace, Inc. reported Operating Income of -$36.98 million for fiscal year 2024. XTI Aerospace, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2024 -$36.98M -387.3% 2023 -$7.59M +60.6% 2022 -$19.24M +73.5% 2021 -$72.74M -205.7% 2020 -$23.79M -14.3% 2019 -$20.81M -13.1% 2018 -$18.40M -22.4% 2017 -$15.03M +36.6% 2016 -$23.72M … Read more
Quick Answer XTI Aerospace, Inc. reported R&D Expense of $4.00 million for fiscal year 2024. XTI Aerospace, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $4.00M +189.4% 2023 $1.38M -69.2% 2022 $4.48M -68.2% 2021 $14.12M +116.5% 2020 $6.52M +67.6% 2019 $3.89M +216.2% 2018 $1.23M +27.7% 2017 $964.0K -57.7% 2016 $2.28M … Read more
Quick Answer XTI Aerospace, Inc. reported Stockholders Equity of $6.57 million for fiscal year 2024. XTI Aerospace, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2024 $6.57M +120.8% 2023 -$31.63M -111.1% 2022 -$14.98M -118.3% 2021 $81.80M +83.3% 2020 $44.64M +641.3% 2019 $6.02M -47.6% 2019 $11.48M -2.2% 2019 $11.74M -9.0% 2019 $12.91M … Read more
Quick Answer XTI Aerospace, Inc. reported Long-Term Debt of $65.0 thousand for fiscal year 2024. XTI Aerospace, Inc. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2024 $65.0K -99.6% 2023 $18.55M +24962.2% 2018 $74.0K -90.4% 2017 $767.0K -81.0% 2016 $4.05M +230.1% 2015 $1.23M +1126.0% 2014 $100.0K -65.8% 2013 $292.0K — Quarterly Long-Term … Read more
Quick Answer XTI Aerospace, Inc. reported Cash and Equivalents of $4.11 million for fiscal year 2024. XTI Aerospace, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2024 $4.11M +82000.0% 2023 $5.0K -99.9% 2022 $9.28M -82.3% 2021 $52.48M +191.6% 2020 $18.00M +276.7% 2019 $4.78M +373.9% 2018 $1.01M +747.1% 2017 $119.0K … Read more